Skip to content
10-Q

Quarterly Report

Aura Biosciences, Inc. AURA

0001193125-26-216808

← back to feed
Filed
May 11, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 8, 2026 103.39M sh
Shares Diluted Q1 2026 · Mar 31, 2026 67.45M sh
Shares Diluted Q1 2026 · Mar 31, 2025 50.13M sh
Capex Q1 2026 · Mar 31, 2026 $102K
Capex Q1 2026 · Mar 31, 2025 $187K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$29.89M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$23.36M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $84.79M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $59.52M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $38.23M
Stockholders Equity Q1 2026 · Mar 31, 2026 $107.25M
Stockholders Equity Q1 2026 · Dec 31, 2025 $136.91M
Stockholders Equity Q1 2026 · Mar 31, 2025 $127.97M
Stockholders Equity Q1 2026 · Dec 31, 2024 $151.97M
Current Liabilities Q1 2026 · Mar 31, 2026 $16.71M
Current Liabilities Q1 2026 · Dec 31, 2025 $18.38M
Total Liabilities Q1 2026 · Mar 31, 2026 $30.43M
Total Liabilities Q1 2026 · Dec 31, 2025 $32.52M
Current Assets Q1 2026 · Mar 31, 2026 $118.5M
Current Assets Q1 2026 · Dec 31, 2025 $149.74M
Total Assets Q1 2026 · Mar 31, 2026 $137.68M
Total Assets Q1 2026 · Dec 31, 2025 $169.43M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.50
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.55
Eps Basic Q1 2026 · Mar 31, 2026 −$0.50
Eps Basic Q1 2026 · Mar 31, 2025 −$0.55
Sga Expense Q1 2026 · Mar 31, 2026 $6.91M
Sga Expense Q1 2026 · Mar 31, 2025 $5.69M
Rd Expense Q1 2026 · Mar 31, 2026 $27.96M
Rd Expense Q1 2026 · Mar 31, 2025 $23.34M
Net Income Q1 2026 · Mar 31, 2026 −$33.69M
Net Income Q1 2026 · Mar 31, 2025 −$27.48M
Operating Income Q1 2026 · Mar 31, 2026 −$34.87M
Operating Income Q1 2026 · Mar 31, 2025 −$29.04M